Cleared Traditional

K790706 - ANTISERUM TO RABBIT IGG H & L CHAIN
(FDA 510(k) Clearance)

K790706 · Kent Laboratories, Inc. · Immunology
Sep 1979
Decision
153d
Days
Class 2
Risk

K790706 is an FDA 510(k) clearance for the ANTISERUM TO RABBIT IGG H & L CHAIN, a Kappa, Antigen, Antiserum, Control (Class II — Special Controls, product code DFH), submitted by Kent Laboratories, Inc. (Mchenry, US). The FDA issued a Cleared decision on September 12, 1979, 153 days after receiving the submission on April 12, 1979. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5550.

Submission Details

510(k) Number K790706 FDA.gov
FDA Decision Cleared SESE
Date Received April 12, 1979
Decision Date September 12, 1979
Days to Decision 153 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary

Device Classification

Product Code DFH — Kappa, Antigen, Antiserum, Control
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.5550

Similar Devices — DFH Kappa, Antigen, Antiserum, Control

All 62
Diazyme Human Kappa (k) Free Light Chain Assay; Diazyme Human Lambda (?) Free Light Chain Assay
K253358 · Diazyme Laboratories, Inc. · Dec 2025
Optilite? Freelite Mx Kappa Free Kit; Optilite? Freelite Mx Lambda Free Kit
K250549 · The Binding Site Group , Ltd. · May 2025
FLC Kappa, FLC Lambda,FLC Control Level 1, FLC Control Level 2
K231601 · Sebia · Feb 2024
Optilite? Freelite? Kappa Free Kit, Optilite? Freelite? Lambda Free Kit
K231290 · The Binding Site, Ltd. · Jan 2024
FLC Kappa, FLC Lambda, FLC Control Level 1, FLC Control Level 2
K210623 · Sebia · Nov 2022
Diazyme Human Kappa Free Light Chain Assay, Diazyme Human Lambda Free Light Chain Assay
K211648 · Diazyme Laboratories, Inc. · Sep 2022